SAREPTA THERAPEUTICS, INC. for SAREPTA THERAPEUTICS, INC.
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 3rd Quarter - Report (this page) | Oct 21, 2019 | $150,000 | Replaced |
| 3rd Quarter - Amendment | Oct 31, 2019 | $150,000 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R.2507/S. 2158 Newborn Screening Saves Lives Reauthorization Act of 2019 Discussions regarding State Medicaid access, innovative payment arrangements for gene therapy and value-based payments (No specific bill)
| Lobbyist | Covered position, as disclosed |
|---|---|
| DIANE BERRY | — |
| STACEY FRISK | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.